Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
https://adler.staging1090.pendari.com/wp-content/uploads/2022/01/rocket-pharmaceuticals-logo.jpeg 589 589 Adler Lab Adler Lab https://adler.staging1090.pendari.com/wp-content/uploads/2022/01/rocket-pharmaceuticals-logo.jpegRocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease